Matinas BioPharma Holdings, Inc.

MTNB · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$5,435$6,525$6,924$7,284
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$218$743$623$741
Total Curr. Assets$5,653$7,268$7,547$8,025
Property Plant & Equip (Net)$1,356$1,626$2,028$2,156
Goodwill$0$0$0$0
Intangibles$0$2,260$2,260$2,260
Long-Term Investments$0$0$200$200
Tax Assets$0$0$0$0
Other NC Assets$2,686$270$0$0
Total NC Assets$4,042$4,156$4,488$4,616
Other Assets$0$0$0$0
Total Assets$9,695$11,424$12,035$12,641
Liabilities
Payables$80$167$282$95
Short-Term Debt$851$822$794$766
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$564$795$1,179$1,805
Total Curr. Liab.$1,495$1,784$2,255$2,666
LT Debt$1,483$1,708$1,920$2,128
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$257$257$257$257
Other NC Liab.$0$0$1,333$0
Total NC Liab.$1,740$1,965$3,510$2,385
Other Liabilities$0$0$0$0
Cap. Leases$0$2,530$2,714$2,894
Total Liabilities$3,235$3,749$5,765$5,051
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$208,875-$206,725-$201,480-$199,824
AOCI$0$0$0$0
Other Equity$215,334$214,399$207,749$207,413
Total Equity$6,460$7,675$6,270$7,590
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$9,695$11,424$12,035$12,641
Net Debt-$3,101-$3,995-$4,210-$4,390
Matinas BioPharma Holdings, Inc. (MTNB) Financial Statements & Key Stats | AlphaPilot